(Q38005351)

English

Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: a report of five cases and review of the literature

scientific article published on 24 April 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: a report of five cases and review of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

author name string

Elizabeth A Jaben

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Jeffrey L Winters

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

publication date

24 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Journal of Clinical Apheresis

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

267-273

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Clinical spectrum of voltage-gated potassium channel autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Management of Voltage-Gated Potassium Channel Antibody Disorders

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Hypothermia in VGKC antibody-associated limbic encephalitis.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Potassium channel antibodies in two patients with reversible limbic encephalitis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Morvan's fibrillary chorea: remission after plasmapheresis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Morvan's fibrillary chorea. Electrodiagnostic and in vitro microelectrode findings.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Antibodies to AChR, synapse-organizing proteins, titin, and other muscle proteins in Morvan's fibrillary chorea

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Sub-acute presentation of Morvan's syndrome after thymectomy

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Neurophysiologic studies in Morvan syndrome

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21233

21 January 2018

Identifiers

10.1002/JCA.21233

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38005351&oldid=2177445205"